entertainment -WSS

entertainment

author：entertainment 2025-09-28 18:31:14 - browse：49

Former MIT and Whitehead Institute star biologist David Sabatini, who lost his positions after he was accused of violating sexual harassment policies in 2021, is resuming his science career, taking a post at a Czech research institute in Prague.

Sabatini, of Cambridge, confirmed in a phone call from Prague that he has accepted a position as a “senior group leader” at the Institute of Organic Chemistry and Biochemistry, known as IOCB Prague. Sabatini said he will be recruiting staff and running a laboratory in the Czech Republic capital to investigate scientific questions in the areas of cell growth and metabolism, similar to his past research in Cambridge.

“I’m very grateful to be given the opportunity to do science again,” said Sabatini, who began working at the institute last month.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Google and Epic fight stronger regulation of AI in health care

WSS

Key House panel plots a new health care package

STAT Virtual Event: The State of Biosimilars: What to Watch

In early work, researchers turn to CRISPR to treat Alzheimer's

STAT Madness 2024: Meet the contenders

'Vaccine

Readout Newsletter: Beam, Prozac, "TechBio" and more

entertainment

entertainment

hotspot

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Readout Newsletter: GSK, Viking Therapeutics, mifepristone news

Tori Bowie and the unacceptable rates of Black maternal death

Redefining sustainability for the pharmaceutical industry

In Memoriam: Notable people who died in 2023

Pfizer is about to make a big push in cancer. Will investors listen?

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Using force crossed my mind when examining a defiant young patient

23andMe had bad news about my health. I wish a person had delivered it

FDA moves to stop vape shops from selling Elf Bar, Esco Bars

focus

Color Health wants to make cancer screenings convenient

Change Healthcare cyberattack shows risk of industry consolidation

ARCH Venture Partners tops STAT's 2023 biotech VC rankings

Sanders adds drug shortage policies to pandemic preparedness bill

NEJM study measures Covid brain fog, impact on IQ

FDA approves RSV monoclonal antibody for infants, toddlers

entertainment

hotspot

focus

focus